Radiofrequency Energy Therapy for Stress Urinary Incontinence

This policy addresses radiofrequency (RF) energy therapies — including transvaginal and transurethral non‑ablative RF procedures (e.g., Renessa/Lyrette approaches) — for treatment of female stress urinary incontinence (SUI), particularly for patients with SUI or persistent SUI after failed conservative therapies. However, these RF treatments are generally considered experimental/investigational and not covered due to limited, short‑term and inconsistent evidence, uncertain long‑term durability, and device‑specific FDA clearance requirements (with conservative therapy required first).

"Stress urinary incontinence (SUI) in women (involuntary urine loss with increased intra-abdominal pressure)."

Sign up to see full coverage criteria, indications, and limitations.